-
Posted by
Two Blokes Jul 22 -
Filed in
Stock
-
9 views
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially positive data readouts.
